Pfizer Demands JAMA’s Notes On Celebrex

CHICAGO (CN) - Pfizer asked the Federal Court to order nonparties The American Medical Association and the Journal of The American Medical Association to turn over "peer review comments, draft manuscripts, and correspondence with the authors" of articles about Celebrex and Bextra. The JAMA is willing to turn over only the published articles. See filing in Bextra and Celebrex Marketing Sales Practices and Product Liability Litigation.

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Email *

Submit